PARP inhibitors are a type of anti-cancer drug. PARP stands for poly-adenosine diphosphate-ribose polymerase, an enzyme that aids in the repair of DNA damage in the cells. PARP inhibitors work by preventing cancer cells and recovering from them, leaving them to die. These drugs are a type of targeted therapy. It can affect the cancer cells, and the potential for prevention of the infection of healthy cells. A PARP inhibitor is a type of prescription medication that helps to treat various forms of cancer. Blocks of PARP enzymes in the human body.
DelveInsight projected that there are many prospective drugs in the PARP Inhibitors pipeline that can enter the market and can alter the entire market scenario.